News
March 12, 2026
Monteris Medical Secures $28 Million in Growth Equity to Accelerate Revenue and Innovation in Minimally Invasive Neurosurgery
Read more >>: Monteris Medical Secures $28 Million in Growth Equity to Accelerate Revenue and Innovation in Minimally Invasive Neurosurgery
March 4, 2026
Monteris Medical Announces New Study Showing NeuroBlate® Laser Ablation May Enhance Immunotherapy Response, Providing Significant Overall Survival Improvement in Recurrent High Grade Brain Tumors
Read more >>: Monteris Medical Announces New Study Showing NeuroBlate® Laser Ablation May Enhance Immunotherapy Response, Providing Significant Overall Survival Improvement in Recurrent High Grade Brain Tumors
January 28, 2026
Monteris Medical Leads Effort to Secure TRICARE Coverage for Laser Interstitial Thermal Therapy (LITT) for Military Members
Read more >>: Monteris Medical Leads Effort to Secure TRICARE Coverage for Laser Interstitial Thermal Therapy (LITT) for Military Members
October 9, 2025
Monteris Medical and Symphony Robotics Announce Strategic Collaboration to Launch AI-Driven Micro-Robotic Platform for Laser Ablation in the Brain
Read more >>: Monteris Medical and Symphony Robotics Announce Strategic Collaboration to Launch AI-Driven Micro-Robotic Platform for Laser Ablation in the Brain
July 15, 2025
Monteris Medical Announces Largest Prospective Publication to Date in JAMA Neurology on LITT for Epilepsy Cohort Using the NeuroBlate® System
Read more >>: Monteris Medical Announces Largest Prospective Publication to Date in JAMA Neurology on LITT for Epilepsy Cohort Using the NeuroBlate® System
April 1, 2025
Monteris Medical Announces Congress of Neurological Surgeons Guidelines Issued on Laser Interstitial Thermal Therapy for the Treatment of Adults with Metastatic Brain Tumors
Read more >>: Monteris Medical Announces Congress of Neurological Surgeons Guidelines Issued on Laser Interstitial Thermal Therapy for the Treatment of Adults with Metastatic Brain Tumors
May 1, 2024
Monteris Medical Announces Market Release of NeuroBlate NB3 FullFire 1.6mm Laser Probe, Smallest Commercially Available Laser Probe for Use in the Brain
Read more >>: Monteris Medical Announces Market Release of NeuroBlate NB3 FullFire 1.6mm Laser Probe, Smallest Commercially Available Laser Probe for Use in the Brain
April 3, 2024
Monteris Medical Announces Publication of Largest Cohort to Date of LITT with NeuroBlate® System for Meningioma, Most Common Primary Brain Tumor
Read more >>: Monteris Medical Announces Publication of Largest Cohort to Date of LITT with NeuroBlate® System for Meningioma, Most Common Primary Brain Tumor